Degradation of Clonazepam in Serum by Light Confirmed by Means of a High Performance Liquid Chromatographic Method
- 1 September 1986
- journal article
- research article
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 8 (3) , 358-360
- https://doi.org/10.1097/00007691-198609000-00021
Abstract
The degradation of clonazepam (CZP) in serum during exposure to light can markedly decrease the concentration of the drug. Decay of CZP was studied after exposure to artificial UV light, sunlight, and room light. Serum was extracted with diethylether at pH 9.1. A reversed-phase (RP-8) column was used, with acetonitrile and water as the mobile phase. CZP was detected at 320 nm. The linearity of this high performance liquid chromatographic method is guaranteed to at least 700 nM. The recovery of CZP was 93%, and the day-to-day coefficients of variation were 7.7% (at 75.0 nM) and 6.0% (at 211.4 nM), respectively.This publication has 4 references indexed in Scilit:
- Simultaneous determination of eleven antiepileptic compounds in serum by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1984
- Quantitation of clonazepam and its 7-amino and 7-acetamido metabolites in plasma by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1984
- Simple and Specific High Performance Liquid Chromatographic Method for the Routine Monitoring of Clonazepam in PlasmaTherapeutic Drug Monitoring, 1980
- Simplified thin-layer chromatographic method for the simultaneous determination of clonazepam, diazepam and their metabolites in serumJournal of Chromatography B: Biomedical Sciences and Applications, 1977